(IN BRIEF) NLB has announced that its voluntary public takeover offer for Addiko Bank AG did not receive enough shareholder acceptances to proceed. The all-cash offer was launched on 13 May 2026 and required acceptance declarations representing at least 50% … Read the full press release
Posted in Austria, Banks, Business, Financial, Investment, Law, Slovenia
Tagged 087, 31.22 percent acceptance, 353 shares, 50 percent plus one share, 6, acceptance declarations, acquisition strategy, Addiko, Addiko Bank AG, Addiko shares, all-cash offer, Austria, Austrian Takeover Act, banking sector, Blaž Brodnjak, Brandes Investment Partners, capital position, EBRD, European Bank for Reconstruction and Development, Johannes Proksch, Keefe Bruyette & Woods, minimum acceptance threshold, NLB, NLB Ends Voluntary Public Takeover Offer Process for Addiko Bank, NLB Reaffirms Southeastern Europe Growth Strategy After Addiko Offer Outcome, NLB Says Capital Position Remains Strong Following Unsuccessful Addiko Takeover Offer, NLB Takeover Offer for Addiko Bank Fails to Reach Minimum Acceptance Threshold, Nova Ljubljanska banka, offer memorandum, offer not extended, payment and settlement agent, public takeover offer, regulatory announcement, Schönherr Rechtsanwälte GmbH, settlement not taking place, shareholder acceptance, Slovenia, Southeastern Europe, Stifel Nicolaus Europe Limited, Takeover Commission, Übernahmekommission, voluntary public takeover offer, Wellington Management
(IN BRIEF) EQT Life Sciences has joined a USD 115 million Series A financing for UK biotechnology company RQ Bio, alongside lead investor Frazier Life Sciences, other new investors and existing backers. The funding will support clinical development of RQB01, … Read the full press release
Posted in Business, Financial, Healthcare, Investment, Pharma & Biotech, Science, Sweden, Technology, United Kingdom
Tagged antibody discovery, antibody therapies, biopharmaceuticals, biotechnology investment, Christian S. Schade, clinical development, EQT Life Sciences, Felice Verduyn-van Weegen, flu season protection, Forbion, Frazier Life Sciences, Halda Therapeutics, high-risk populations, immunocompromised patients, infectious diseases, influenza prevention, LifeArc, Mike Westby, Monograph, New Series A Financing Supports RQB01 Development for High-Risk Influenza Patients, Oxford Science Enterprises, Oxford University Innovation, preventive therapy, rare and vulnerable patient populations, respiratory viral diseases, RQ Bio, RQ Bio Expands Investor Base and Appoints Christian S. Schade as Executive Chairman, RQ Bio Secures Major Funding Round for Antibody-Based Respiratory Disease Prevention Pipeline, RQB01, seasonal influenza, Series A financing, Wellington Management
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?